| Date Filed | Type | Description |
| 10/03/2023 |
4
| Farrell Michael J. (Director) has filed a Form 4 on ZIMMER BIOMET HOLDINGS, INC.|
Txns:
| Granted 321 options to buy
@ $0 |
|
| 08/18/2023 |
4
| Farrell Michael J. (CEO) has filed a Form 4 on RESMED INC|
Txns:
| Granted 12,430 shares
@ $0 |
|
| 08/17/2023 |
4
| Farrell Michael J. (CEO) has filed a Form 4 on RESMED INC|
Txns:
| Sold 5,675 shares
@ $183.1977, valued at
$1M
Exercised 5,675 options to buy
@ $57.76, valued at
$327.8k
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/12/2023 |
4/A
| Farrell Michael J. (Director) has filed a Form 4 on ZIMMER BIOMET HOLDINGS, INC.|
Txns:
| Granted 247 options to buy
@ $0 |
|
| 07/05/2023 |
4
| Farrell Michael J. (Director) has filed a Form 4 on ZIMMER BIOMET HOLDINGS, INC.|
Txns:
| Granted 213 options to buy
@ $0 |
|
| 06/16/2023 |
4
| Farrell Michael J. (CEO) has filed a Form 4 on RESMED INC|
Txns:
| Sold 5,675 shares
@ $217.3949, valued at
$1.2M
Exercised 5,675 options to buy
@ $57.76, valued at
$327.8k
|
|
| 05/17/2023 |
4
| Farrell Michael J. (CEO) has filed a Form 4 on RESMED INC|
Txns:
| Sold 5,675 shares
@ $232.1041, valued at
$1.3M
Exercised 5,675 options to buy
@ $57.76, valued at
$327.8k
|
|
| 05/16/2023 |
4
| Farrell Michael J. (Director) has filed a Form 4 on ZIMMER BIOMET HOLDINGS, INC.|
Txns:
| Granted 500 options to buy
@ $0
Granted 951 restricted stock units
@ $0 |
|
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/04/2023 |
4
| Farrell Michael J. (Director) has filed a Form 4 on ZIMMER BIOMET HOLDINGS, INC.|
Txns:
| Granted 243 options to buy
@ $0 |
|
| 03/17/2023 |
4
| Farrell Michael J. (CEO) has filed a Form 4 on RESMED INC|
Txns:
| Sold 5,675 shares
@ $206.9517, valued at
$1.2M
Exercised 5,675 options to buy
@ $57.76, valued at
$327.8k
|
|
| 03/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| Farrell Michael J. (Director) has filed a Form 4 on ZIMMER BIOMET HOLDINGS, INC.|
Txns:
| Granted 294 options to buy
@ $0 |
|
| 09/19/2022 |
4
| Farrell Michael J. (CEO) has filed a Form 4 on RESMED INC|
Txns:
| Sold 5,675 shares
@ $228.9579, valued at
$1.3M
Exercised 5,675 options to buy
@ $57.76, valued at
$327.8k
|
|
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|